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Positive-strand RNA viruses replicate their genomes in membrane-associated structures; 2 
alphaviruses and many other groups induce membrane invaginations called spherules. Here, we 3 
established a protocol to purify these membranous replication complexes (RCs) from cells infected 4 
with Semliki Forest virus (SFV). We isolated SFV spherules located on the plasma membrane and 5 
further purified them using two consecutive density gradients. This revealed that SFV infection 6 
strongly modifies cellular membranes. We removed soluble proteins, the Golgi and most of the 7 
mitochondria, but plasma membrane, endoplasmic reticulum (ER) and late endosome markers 8 
enriched in the membrane fraction that contained viral RNA synthesizing activity, replicase 9 
proteins and minus- and plus-strand RNA. Electron microscopy revealed that the purified 10 
membranes displayed spherule-like structures with a narrow neck. This membrane enrichment 11 
was specific to viral replication as such a distribution of membrane markers was only observed 12 
after infection. Besides the plasma membrane, SFV infection remodeled the ER, and the co-13 
fractionation of the RC-carrying plasma membrane and ER suggests that SFV may recruit ER 14 
proteins or membrane to the site of replication. The purified RCs were highly active in synthesizing 15 
both genomic and subgenomic RNA. Detergent solubilization destroyed the replication activity 16 
demonstrating that the membrane association of the complex is essential. Most of the newly 17 
made RNA was in double-stranded replicative molecules but the purified complexes also produced 18 
single-stranded RNA as well as released newly made RNA. This indicates that the purification 19 
established here maintained the functionality of RCs and thus enables further structural and 20 




Similar to all positive-strand RNA viruses, the arthropod-borne alphaviruses induce membranous 25 
genome factories but little is known about the arrangement of viral replicase proteins and the 26 
presence of host proteins in these replication complexes. To improve our knowledge of alphavirus 27 
RNA-synthesizing complexes, we isolated and purified them from infected mammalian cells. 28 
Detection of viral RNA and in vitro replication assays revealed that these complexes are abundant 29 
and highly active when located on the plasma membrane. After multiple purification steps, they 30 
remain functional in synthesizing and releasing viral RNA. Besides the plasma membrane, markers 31 
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for the endoplasmic reticulum and late endosomes enriched with the replication complexes 32 
demonstrating that alphavirus infection modified cellular membranes beyond inducing replication 33 
spherules on the plasma membrane. We have here developed a gentle purification method to 34 
obtain large quantities of highly active replication complexes, and similar methods can be applied 35 
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RNA viruses play a major role in emerging and re-emerging epidemics, and the most common RNA 43 
viruses have a single-stranded genome of messenger-RNA polarity, i.e. positive-strand RNA (1, 2). 44 
During replication, the genomic RNA serves as a template in the synthesis of a minus strand, which 45 
then serves to produce more plus-strand RNAs (3). All eukaryotic positive-strand RNA viruses 46 
replicate their genomes in membrane-associated complexes that concentrate replication 47 
components, provide a structural framework and protect viral RNA from host defense mechanisms 48 
(4-6). Depending on the virus, the replication membrane originates from the plasma membrane or 49 
subcellular organelles such as mitochondria. Two main types of replication-associated membrane 50 
modifications have been recognized (5). One type are double-membrane vesicles in which typically 51 
multiple vesicles are interconnected via their outer membrane (7-10). The other type are vesicle-52 
like membrane invaginations called spherules, and the current view is that one or multiple double-53 
stranded RNA (dsRNA) intermediates, and thus the negative-strand RNA, reside within a spherule 54 
and newly made, mature positive strands are released to the cytoplasm via a narrow neck that is 55 
wide enough to allow the import of nucleotides and the export of positive-strand RNAs (11-16). 56 
As a model system to study spherule invaginations we use an arthropod-borne alphavirus, 57 
Semliki Forest virus (SFV). Alphaviruses are found on all continents and are known to cause 58 
diseases ranging from mild febrile illnesses to encephalitis and prolonged arthritis (17). SFV is a 59 
close relative of the re-emerged chikungunya virus (CHIKV) that causes arthralgia persisting in 60 
some cases for years (18, 19). The alphavirus genome encodes two polyproteins. The 61 
nonstructural polyprotein P1234 is first cleaved to P123 and nonstructural protein 4 (nsP4), which 62 
form an early replication complex (RC) that synthesizes minus-strand RNA using the genome as a 63 
template (20, 21). Further cleavage of P123 then yields a late RC consisting of nsP1 to nsP4 and 64 
making plus strands from the minus-strand RNA (20). nsP4 is the core RNA-dependent RNA 65 
polymerase (RdRp) but RNA synthesis requires also nsP1, which is the capping enzyme and 66 
membrane anchor of RCs, nsP2, which is the protease and helicase, and nsP3, which interacts with 67 
multiple host proteins (20, 22-31). The second polyprotein, which is translated from a subgenomic 68 
RNA, is cleaved to the capsid and envelope proteins (3). 69 
The role of spherules in alphavirus replication was suggested in the 1960s and 1970s when it 70 
was observed that viral RNA synthesis co-localizes with spherule-carrying cytopathic vacuoles 71 
(CPVs) in infected cells and the RNA-synthesizing activity, viral RNA and CPVs were found to be 72 
enriched in the same fraction after isolation (32-34). Spherules (diameter of ~50 nm) contain 73 
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electron dense material and can be immunostained for dsRNA, indicating that the replicative 74 
dsRNAs are located inside the spherules (35, 36). Furthermore, nsPs co-localize with CPVs and with 75 
dsRNA staining (15, 35, 37), and it has been shown that the template RNA length determines 76 
spherule size strengthening the view of spherules as replication sites (13). Although CPVs revealed 77 
the role of spherules in viral RNA replication, spherules are first formed at the plasma membrane. 78 
In SFV-infected cells, spherules are then internalized and after fusion with late endosomes they 79 
accumulate in perinuclear area in CPVs (15). In contrast, Sindbis virus (SINV) and CHIKV spherules 80 
predominantly stay on the plasma membrane (35, 38). 81 
Functional in vitro studies on alphavirus replication have to a large extent focused on crude 82 
membrane preparations showing that most of the minus-strand RNA as well as RNA-synthesizing 83 
activity are found in a membrane pellet prepared from infected cells (11, 39). Alphaviruses 84 
synthesize in cells and in vitro the same RNA species, genomic and subgenomic single-stranded 85 
RNA (ssRNA) as well as double-stranded replicative forms (RFs) and replicative intermediates (RIs) 86 
(11, 40, 41). In addition, RNA II corresponding to the 5’ end of the genome up to the subgenomic 87 
promoter is made but its function remains unclear (11, 39, 42). However, only RNA of positive 88 
polarity is synthesized in vitro (11, 39). Cytosolic host factors are not required in alphavirus RNA 89 
synthesis in vitro in contrast to positive-strand RNA nidoviruses (11, 39, 43-45). In order to study 90 
both the structure and the molecular mechanisms of these membranous RCs, purified and active 91 
complexes must be obtained. Alphavirus RCs have been purified in sucrose- and glycerol-density 92 
gradients indicating that these complexes are indeed membrane associated (32, 40, 41, 45-47). 93 
However, purification, which may include detergent solubilization, often yields poor replication 94 
activity and only two to three virus-specific proteins have been observed in these complexes. 95 
Thus, we still lack an approach to obtain purified, fully functional complexes amenable for 96 
structural studies such as cryo-electron microscopy, and there is no structure available for the 97 
alphavirus RCs or RdRp. 98 
Here we report a purification method for SFV RCs, and our aim was to maintain the 99 
functionality, integrity and morphology of the RCs that enables us to study their biological 100 
mechanisms. First, we show that RCs isolated from SFV-infected cells are stable and then further 101 
purify these. We demonstrate that the purified RCs are highly active in RNA synthesis and release 102 
newly synthesized RNA strands. We also show that SFV infection causes extensive modification of 103 
cellular membranes by inducing spherules on the plasma membrane, but the effects reach 104 





Isolated SFV RCs are stable 108 
A number of parameters were tested to study if SFV RCs preserve their replication activity under 109 
different conditions and are thus amenable for purification. Metabolic labeling has shown that SFV 110 
RCs are most active in RNA synthesis in baby hamster kidney (BHK) cells at 4-5 h p.i. at a MOI of 50 111 
(39). Thus, post-nuclear supernatant (PNS) was prepared from SFV-infected cells (MOI of 50) at 4 h 112 
p.i. and in vitro RNA synthesis was analysed by measuring the incorporation of 32P-CTP into viral 113 
RNA (Fig. 1). Incorporation was readily detected after a 5-min reaction time, and the signal rapidly 114 
increased up to 60 min (Fig. 1A and B). Consequently, 1-h reaction time was routinely used unless 115 
otherwise stated. Furthermore, SFV PNS could be diluted at least 100-fold without the loss of 116 
replication activity (Fig. 1C). 117 
The highly active and robust RNA synthesizing activity in vitro, which tolerated dilution, 118 
indicated that SFV RCs are suitable for purification. Next we tested if RCs remain active during the 119 
prolonged incubation times that are required to perform the purification procedures. The 120 
complexes remained active throughout a 48-h incubation at 4°C (Fig. 1D). In-gel hybridization 121 
revealed that the endogenous minus-strand RNA was also stable while most of the endogenous 122 
plus-strand RNA was digested already after 3 h (Fig. 1E). This confirms the idea that in cells most 123 
plus strands are released to the cytosol, and thus in PNS they are susceptible to cellular RNases, 124 
and the minus-strand RNA resides inside the spherules as part of double-stranded RNA molecules 125 
in a form that protects them from nucleases. We also determined the stability of RCs in the 126 
density gradient medium iodixanol, which is used for subcellular fractionation, and after a 24-h 127 
incubation, RCs were still highly active and minus-strand RNA was stable (Fig. 1D and E). Bovine 128 
serum albumin (BSA; 1 mg/ml) was observed to boost in vitro replication, on average about 120% 129 
(Fig. 1D). Thus, in further experiments BSA was routinely used in the reaction mixture. SFV RNA 130 
synthesis in vitro could be inhibited by the chain terminator 3’-dCTP (Fig. 1D). 131 
Then, we determined the tolerance of detergents using PNS and the in vitro replication 132 
system. In vitro replication activity of SFV RCs was sensitive to all detergents tested but more 133 
sensitive to anionic sodium deoxycholate (DOC) and sodium dodecyl sulfate (SDS) than to non-134 
ionic n-Octylglucoside and Triton X-100 (Tx-100) (Fig. 1F). 1% DOC and SDS caused the loss of both 135 
the minus-strand template and replication activity indicating that spherules were destroyed and 136 
the minus-strand RNA was exposed to cellular nucleases (Fig. 1F). In contrast, about 80% and 90% 137 
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of the minus-strand RNA present in the untreated sample was recovered after 1% n-Octylglucoside 138 
and Tx-100 treatments, respectively. Thus, here the partial loss of the activity could be due to 139 
disruption of protein-membrane interactions. 140 
Finally, we tested which subcellular location of spherules is the most suitable for purification 141 
by utilizing drug treatments. It has been reported that wortmannin blocks SFV spherules mainly on 142 
the plasma membrane, while nocodazole treatment leads to their accumulation in small endocytic 143 
vesicles (15). In the absence of drugs, spherules accumulate in CPVs. PNS was prepared from 144 
untreated and drug-treated cells infected at a MOI of 500 and collected at 4 h p.i. Quantification of 145 
in-gel hybridizations showed that PNS from wortmannin-treated cells contained the highest 146 
amount of endogenous minus- and plus-strand RNA indicating that also the number of RCs was 147 
the highest (Fig. 2A and B). Importantly, RCs were highly active in RNA synthesis in vitro 148 
independent of their subcellular location, although wortmannin-treated samples gave the highest 149 
activity (Fig. 2C). The observed in vitro RNA synthesis was consistent with that obtained in cells 150 
using metabolic labeling (15). The wortmannin treatment and a MOI of 500 resulted in about the 151 
same amount of the minus-strand RNA as a MOI of 50 without drug treatment (Fig. 2B). However, 152 
the amount of the plus-strand RNA was doubled (Fig. 2A). This phenomenon was also observed 153 
with nocodazole-treated and untreated cells infected at a MOI of 500 when compared to 154 
untreated cells infected at a MOI of 50 (Fig. 2A and B). If we assume that the minus-strand RNA 155 
represents spherules, this indicates that at the higher MOI, RCs are formed faster and have more 156 
time to synthesize plus strands. 157 
 158 
SFV RCs distribute in both the supernatant and the mitochondrial pellet 159 
Due to the high abundance and activity, we chose to purify plasma membrane-derived spherules 160 
and the optimized purification method is summarized in Fig. 3. SFV-infected cells (MOI 500) were 161 
treated with wortmannin at 1.5 h p.i. and harvested in an isotonic homogenization buffer at 4 h 162 
p.i. Dounce homogenization was used to lyse cells in the previous assays, but it caused disruption 163 
of mitochondria and thus cells were lysed for RC purification by passaging through a 22-G needle. 164 
Nuclei and any remaining intact cells were removed by differential centrifugation yielding PNS. 165 
Further centrifugation to remove mitochondria at 7,000 × g yielded a P7 pellet and S7 166 
supernatant. The same amount of cells were seeded for mock and virus infection but when cells 167 
were collected, mock samples contained twice the amount of cells compared to the infected 168 
samples. However, both cell lysates contained similar amounts of proteins (~13 mg/ml) indicating 169 
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that there were more proteins in infected cells than in mock cells. PNS (~3.2 mg/ml) and S7 (~2.6 170 
mg/ml) prepared from SFV-infected cells contained more protein than the corresponding samples 171 
from mock cells (~2.0 mg/ml in PNS and ~1.7 mg/ml in S7) indicating that infected cells lysed 172 
better than mock cells. 173 
Most of the proteins and about half of the lipids present in mock and SFV PNS distributed to 174 
S7 (Fig. 4A and B). In order to detect lipids, we utilized an approach to stain lipoproteins with 175 
Sudan Black B after polyacrylamide gel electrophoresis (see Materials and Methods). However, 176 
gels were stained after a short electrophoresis to allow detection of species below a 10-kDa 177 
marker. Distribution of different viral and cellular markers was further studied by Western blotting 178 
(Fig. 4C). Most of nsP2, nsP3 and nsP4 as well as about 50% of nsP1 were found in the viral S7. SFV 179 
capsid protein was also mainly found in the S7 fraction. The Golgi matrix protein of 130 kDa 180 
(GM130), the endoplasmic reticulum (ER) marker calnexin, the mitochondrial marker succinate 181 
dehydrogenase subunit A (SDHA), and the cytosolic marker β-actin showed a similar distribution 182 
into S7 and P7 fractions in both mock and virus samples. GM130 was exclusively detected in S7 183 
and β-actin was more prominent in S7 than in P7. Most of SDHA distributed in the P7 pellet, and 184 
about half of calnexin was found in S7. About half of the plasma membrane calcium pump ATPase 185 
(PMCA) was found in the mock S7 while in the virus-infected samples it was more prominent in S7 186 
than in P7. In both mock and virus-infected samples the late endosomal marker Rab7 was more 187 
prominent in S7 than in P7 but the enrichment was stronger in the mock samples. 188 
In vitro replication activity present in the viral PNS, S7 and P7 fractions was analysed by 189 
quantifying the incorporation of 32P-CTP into SFV 42S RNA (Fig. 4D). About 50% and 30% of the 190 
PNS activity was recovered in S7 and P7, respectively. In-gel hybridization showed that the minus-191 
strand RNA distributed equally to S7 and P7 (Fig. 4E) indicating that differential centrifugation 192 
caused a partial loss of replication activity in the pellet fraction. Approximately 60% of the 193 
genomic RNA was found in S7.  194 
 195 
SFV infection modifies the properties of cellular membranes 196 
We selected the S7 fraction for further purification in density gradients (Fig. 5 and 6) as more than 197 
half of the active RCs remained in this fraction. RCs were first purified from the S7 fractions by 198 
sedimentation in a 10-20% iodixanol-step gradient (Fig. 3) by loading 500 µl of S7 on the top of a 199 
12-ml density gradient, resulting in ~0.9 and 1.3 mg of proteins loaded from mock and virus-200 
infected samples, respectively. Signals from the cellular markers were comparable in the S7 201 
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fractions from mock and SFV-infected cells (Fig. 5 and 6). After sedimentation, a light-scattering 202 
band was detected in every interphase as well as close to the gradient surface. Gradients were 203 
fractionated, and the protein pattern in each fraction was determined by SDS-PAGE (Fig. 5A). Most 204 
proteins stayed in the top fractions of sedimentation gradients derived from the S7 fraction of 205 
mock (labeled mock) or SFV-infected (labeled SFV) cells, although the latter resulted in the 206 
detection of more proteins especially in fr. 5. Lipids were detected in all fractions that correspond 207 
to the bands and in the pellet (Fig. 5B). In both gradients, lipids concentrated in fr. 5 and 6 (band 208 
3). However, fr. 3 and 4 (band 2) of the mock gradient contained more lipids than the 209 
corresponding fractions of the SFV gradient. 210 
Western blotting revealed the distribution of viral and cellular markers between gradient 211 
fractions (Fig. 5C). In the SFV gradient, nsPs concentrated in fr. 1, 3-4 and 5-6 corresponding to 212 
bands 1, 2 and 3, respectively. SFV capsid protein was observed in fr. 1-8. The Golgi marker stayed 213 
on the top of both gradients, and the remaining mitochondrial marker was mainly on the top and 214 
a minor amount was detected in fr. 5. In the mock gradient, the plasma membrane marker PMCA 215 
mostly stayed on the top while in the SFV gradient it concentrated in fr. 1 and 5-6 (band 3). To 216 
further study the distribution of the plasma membrane, another plasma membrane marker, Na,K 217 
ATPase, was included, and this marker gave similar distribution in the sedimentation gradients as 218 
PMCA although PMCA showed stronger concentration in fr. 5-6 (band 3) in the SFV gradient. The 219 
late endosomal marker Rab7 predominantly stayed on the top of the mock gradient while in SFV it 220 
concentrated in both fr. 1 and 5-6 (band 3). Lysosome-associated membrane protein 2 (LAMP-2), 221 
which is a marker for the late endosomes and lysosomes, showed a different distribution 222 
compared to Rab7. In the mock gradient LAMP-2 concentrated in fr. 2-5 and in the SFV gradient in 223 
fr. 1-5. The ER marker calnexin concentrated in the mock gradient in fr. 3-4 (band 2) and fr. 5-6 224 
(band 3) and in the SFV gradient in fr. 5-6 (band 3). To further examine ER distribution, two 225 
additional markers for ER were included. CLIMP-63 (cytoskeleton-linking membrane protein 63), 226 
also known as CKAP-4 (cytoskeleton-associated protein 4), is predominantly found in ER sheets 227 
(48) and reticulon 4B (RTN4B), also known as Neurite outgrowth inhibitor B (Nogo-B), localizes to 228 
ER tubules and sheet edges (49). CLIMP-63 showed a similar distribution as calnexin although an 229 
additional band was detected in fr. 1. RTN4B was found in fr. 1-5 of the mock gradient while in the 230 
SFV gradient RTN4B concentrated in fr. 5-6 (band 3) similar to calnexin and CLIMP-63. The 231 
cytosolic marker β-actin concentrated in the top fractions but in the SFV gradient it was also found 232 
in fr. 5-6 (band 3). We also tested addition of 150 mM KCl to the cell lysate if higher salt 233 
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concentration was required to keep membranes from aggregating but no effect in sedimentation 234 
was observed indicating that the results were not due to unspecific membrane aggregation. 235 
An in vitro replication assay showed that most of SFV replication activity was in fr. 5-6 (band 236 
3) of the sedimentation gradient (Fig. 7B) and thus this band at density of 1.10-1.11 g/ml was 237 
collected for further purification. The final step in the purification was equilibrium centrifugation 238 
in a 10-30% iodixanol-step gradient as shown in Fig. 3. After flotation, two light-scattering bands 239 
were observed and gradients were fractionated. Fr. 10-12 represent 30% iodixanol containing the 240 
band 3 collected from the sedimentation gradient. The upper band in the flotation gradient (band 241 
1 in Fig. 3) was considerably weaker than the other band (band 2 in Fig. 3) and detectable proteins 242 
and lipids concentrated in the area of the band 2 or lower fractions. Coomassie staining revealed 243 
very little protein in the mock fractions (Fig. 6A). In the SFV gradient, proteins were mainly 244 
observed in fr. 4 (band 2) as well as in fr. 9-12. Lipids were detected in both gradients in fr. 4 albeit 245 
SFV gave a much stronger signal (Fig. 6B). In the mock gradient, Western blotting detected only a 246 
weak calnexin signal in fr. 3 and 4 (Fig. 6C). In the SFV gradient, nsPs and capsid protein 247 
concentrated in fr. 4, except for that nsP2 and capsid were also detected in fr. 9-12 indicating that 248 
nsP2 and capsid protein in these fractions did not float and thus were not membrane associated. 249 
The plasma membrane marker PMCA, late endosome marker Rab7 and ER marker calnexin also 250 
concentrated in fr. 4. In addition, β-actin and the residual mitochondria were detected in fr. 4. 251 
Golgi was hardly detectable. The density in fr. 4 was 1.11 g/ml. As viral nsPs and PMCA, Rab7 and 252 
calnexin concentrated in fr. 4 in the SFV gradient, fr. 3-5 were further studied using additional 253 
cellular markers (Fig. 6D). The plasma membrane marker Na,K ATPase as well as ER markers 254 
CLIMP-63 and RTN4B also concentrated in fr. 4 in the SFV gradient while these markers were 255 
undetectable in the mock fr. 3-5. Interestingly, LAMP-2, a marker for the late endosomes and 256 
lysosomes, was undetectable in fr. 3-5 of both mock and SFV gradient. 257 
We next assayed where SFV minus- and plus-strand RNA as well as 18S ribosomal RNA 258 
(rRNA) distributed in the sedimentation and flotation gradients (Fig. 7A). 18S rRNA concentrated in 259 
sedimentation fr. 4, and only a small amount was detected after flotation, in fr. 9-12 indicating 260 
that the detected rRNA did not float. After sedimentation, the minus- and plus-strand RNA were 261 
mainly recovered in fr. 1, 3-4 and 5-6, and after flotation, both concentrated in fr. 4. 262 
Approximately 20% of the minus-strand RNA present in S7 was recovered in flotation fr. 4. 263 
In both sedimentation and flotation gradients 32P-CTP incorporation co-localized with the 264 
endogenous minus-strand RNA (Fig. 7), and high in vitro replication activity was observed after the 265 
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purification. The RCs in the flotation fr. 4 (band 2) were designated as purified RCs and collected 266 
for further characterization. The average protein concentration of the purified RCs from three 267 
purifications was 0.02 mg/ml indicating that less than 1% of the proteins present in S7 were 268 
remaining. However, the recovery of the activity present in S7 was approximately 20% when the 269 
32P-CTP incorporation into the genomic RNA was compared (Fig. 7C). The purified RCs synthesized 270 
both genomic and subgenomic RNA but RNA II was observed only in sedimentation fr. 1 and 3 (Fig. 271 
7B and C). 272 
 273 
Purified RCs display spherule-like structures and release newly made RNA 274 
Electron microscopy of the purified RCs and the corresponding membrane fraction from mock cells 275 
revealed sheets, vesicles and some tubule-like membranes (Fig. 8). Sheets, which might be derived 276 
from the plasma membrane or ER, were observed in both samples (Fig. 8A). Sheets or vesicles with 277 
multiple, spherical invaginated membranes were typical of the purified RCs and could not be 278 
detected in the mock samples (Fig. 8B-I). The diameter of these invaginations was similar to that of 279 
spherules, about 50 nm, and some of them showed a dark spot in the middle, most likely 280 
representing RNA. In addition, membrane sheets displaying smaller round structures, which may 281 
represent narrow spherule necks, were observed (Fig. 8C). A few nucleocapsids were also found 282 
close to the spherule-like structures (Fig. 8D).  283 
To determine the stability of the newly made RNA, in vitro replication reactions were 284 
terminated by adding the nucleoside analogue 3’-dCTP followed by a chase for 3 h (Fig. 9A). In the 285 
unterminated control samples, the amount of the 32P-CTP-labeled genomic RNA increased 286 
approximately 1.7-fold or 2.5-fold in the reactions containing the S7 or purified RCs, respectively. 287 
After termination, the level of the labeled genomic RNA slowly decreased in both S7 and purified 288 
RCs, with a similar rate. However, the half-life was more than 180 min. In contrast, when a capped 289 
in vitro transcript of Tmed RNA, which contains the SFV 5’ and 3’ untranslated regions as well as 290 
the subgenomic promoter, was added in the reactions, it was rapidly degraded in the S7 sample 291 
and the half-life was less than 15 min. This indicated that the newly synthesized SFV RNA was 292 
protected in the S7 sample and for CHIKV, it has been proposed that membrane or polysome 293 
association, RNA structure or encapsidation protects newly made ssRNA from cellular nucleases 294 
(11). In the reaction mixture containing purified RCs, the Tmed RNA was approximately as stable 295 




As added RNA remained relatively stable in the purified preparations, we tested if the 298 
purified RCs are able to utilize an exogenous template RNA. However, no additional RNA products 299 
were synthesized when the Tmed template was provided in addition to the endogenous one (Fig. 300 
9B) indicating that once a functional RC has been formed it is unable to replicate another 301 
template. We also tested if RCs remained sensitive to detergents now when cellular nucleases 302 
were removed by purification. After 1% Tx-100 treatment, the minus-strand template remained 303 
stable while replication activity was almost completely lost (Fig. 9C) indicating that the detergent 304 
sensitivity was not (solely) due to exposure to nucleases but due to solubilization of the 305 
membrane-associated RCs. 306 
Next, we assessed incorporation of 32P-CTP into ssRNA, RF and RI by isolating RNA after a 307 
replication assay with the purified RCs and treating the isolated RNA with RNases. RF and RI are 308 
fully and partially double-stranded RNA molecules, respectively, and under high salt conditions, 309 
RNase A/T1 should digest free ssRNA and single-stranded overhangs of RIs and thus the full-length 310 
32P-labeled RNA observed after the digestion in a denaturing gel is mainly derived from RFs. RNase 311 
III should digest RF and double-stranded regions of RIs and after such a treatment, the full-length 312 
32P-labeled RNA observed in a denaturing gel is mainly derived from ssRNAs. 64% and 19% of the 313 
radiolabeled genomic RNA present in the untreated sample was recovered after the RNase A/T1 314 
and III treatments in the denaturing electrophoresis, respectively (Fig. 9D). Thus, approximately 315 
60% of the newly synthesized RNA was in RF, 20% in RI and 20% in free ssRNAs. However, after 316 
both treatments signal might remain that contained an almost full-length 32P-labeled RNA 317 
(annealed with the minus-strand template) or an almost full-length 32P-labeled single-stranded 318 
overhang. Non-denaturing electrophoresis also supported the presence of both RF and RI because 319 
the RF/RI signal was reduced approximately 32% after the A/T1 digestion. Most likely single-320 
stranded overhangs in RI were digested and thus the signal was reduced. The untreated and RNase 321 
III-treated samples gave equally strong ssRNA signals, whereas after the A/T1 treatment no ssRNA 322 
was observed in a non-denaturing gel. The RNase treatments also indicate that SFV replication is 323 
semi-conservative because after the A/T1 digestion under high salt conditions, 32P-labeled 324 
genomic RNA was detected in the denaturing gel (Fig. 9D). This is possible only if the labeled RNA 325 
was in a dsRNA molecule. If replication were conservative, such a form would not exist. 326 
To determine whether the ssRNAs synthesized by the purified RCs were released, we studied 327 
their membrane association. For this, the purified RCs were concentrated to remove iodixanol, 328 
and after a replication assay pellet and supernatant were separated to detect membrane-329 
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associated and free RNA. Most of the 32P-labeled RNA stayed associated with the pellet fraction 330 
after the replication assay (Fig. 9E). However, 32P-labeled 26S and 42S RNA were also detected in 331 
the supernatant and their amount increased in the same rate in both pellet and supernatant 332 
fraction indicating that the more RNA was synthesized, the more RNA was found in the 333 
supernatant. At every time point approximately 30% of the labeled genomic RNA was found in the 334 
supernatant, which is close to the amount of ssRNA approximated based on the RNase treatments 335 
(Fig. 9D and E). 336 
Both the presence of newly made RNA in RIs (Fig. 9D) and release of newly made strands 337 
(Fig. 9E) indicated that de novo initiation might occur in vitro. In addition, the linear rate of RNA 338 
synthesis in the unterminated RC samples (Fig. 9A) indicated that the purified RCs might be able to 339 
initiate new strands. Thus, we approached this question by determining how much the amount of 340 
viral RNA increases during in vitro replication compared to the amount of RNA present in the RCs 341 
after the purification. We have previously shown that SFV RCs mainly synthesize RNA of positive 342 
polarity in vitro (39), and thus here we detected plus-strand RNA using a probe that recognizes an 343 
early part of the SFV4 genome (nucleotides 95-121). After a 4-h in vitro replication assay at 30°C 344 
using unlabeled NTPs, RNA was isolated and genomic RNA was detected by in-gel hybridization. In 345 
this sample both in-cell made RNA present in the purified RCs as well as in vitro synthesized, newly 346 
made RNA are detected. For comparison, RNA was also isolated from a reaction, which contained 347 
no added NTPs, and from a sample, which contained only purified RCs and was not incubated at 348 
30°C. In these samples, only RNA made in cells and present in the purified RCs is detected if we 349 
assume that the purified RCs contain no significant amount of cellular NTPs. During in vitro RNA 350 
synthesis, the amount of completed genomic RNA increased 50% in the active samples compared 351 
to the controls without NTPs or without incubation (Fig. 9F). Thus, this result also supports the 352 
possibility of de novo initiation during in vitro RNA synthesis and, at least, indicates active 353 




Our present study demonstrates that the virus-induced plasma membrane invaginations, i.e. 356 
spherules, represent the active replication complexes of alphaviruses. We showed here that all 357 
four viral nsPs, minus- and plus-strand RNA as well as RNA-synthesizing activity were found in the 358 
same purified membrane fraction displaying spherule-like structures on the plasma membrane 359 
sheets (Fig. 6-8). 360 
Previous purification attempts of alphavirus RCs have mainly focused on the isolation of 361 
CPVs (32, 40, 45-47, 50). However, spherules are formed on the plasma membrane and 362 
internalization is not typical of all alphaviruses (15, 35, 38). Here, we observed that SFV RCs were 363 
most abundant and active when isolated from infected cells treated with wortmannin (Fig. 2), 364 
which leads to the retention of the majority of spherules on the plasma membrane (15), and thus 365 
we chose to purify spherule-carrying plasma membrane sheets. Firstly, we homogenized cells in 366 
isotonic buffer using a needle, instead of hypotonic buffer and a Dounce homogenizer such as 367 
used in several previous protocols (32, 40, 41, 45-47). Secondly, we purified RCs from a post-368 
nuclear and -mitochondrial supernatant instead of a membrane pellet (40, 45-47) as differential 369 
centrifugation causes a partial loss of activity (Fig. 4) (11, 39). Thirdly, we observed that SFV RCs 370 
were sensitive to detergents (Fig. 1F) and thus detergent solubilization was excluded. Fourthly, we 371 
used two consecutive density gradients of iodixanol under isotonic conditions. Our purification 372 
protocol yielded RCs that were highly active in synthesizing both genomic and subgenomic RNA as 373 
well as released newly made strands (Fig. 9). In addition, our purification method produced highly 374 
active complexes in large quantities as from ~107 cells, we purified enough RCs to make at least 375 
one hundred standard in vitro replication assays, and it can easily be further scaled up. 376 
The sedimentation analyses revealed that SFV infection extensively modifies cellular 377 
membranes (Fig. 5). The plasma membrane had higher density, most likely due to the RNA-378 
containing RCs. Furthermore, major differences in three ER markers were observed and the ER 379 
showed increased density after infection, indicating that SFV may cause ER re-modelling. Several 380 
viruses are known to affect ER organization. For example herpes simplex virus 1 (HSV-1) infection 381 
results in compression of ER around the nuclear membrane, most likely to facilitate nuclear egress 382 
of HSV-1 nucleocapsids (51). SFV infection also affected the late endosomal and lysosomal 383 
markers. Consequently, SFV has more profound effects on the membrane dynamics of the host 384 
cell than merely inducing plasma membrane invaginations. 385 
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Purification of the RCs resulted in a replication-active membrane fraction enriched with the 386 
markers for the plasma membrane, ER and late endosomes (Fig. 6). We could remove soluble 387 
proteins, the Golgi, and most of the mitochondria. The corresponding membrane fraction from 388 
mock cells revealed only a minor signal for the ER marker calnexin indicating that we purified a 389 
virus-specific network of membranes associated with replication. In cells, the peripheral ER 390 
tubules form a branched network contacting the cytoskeleton, plasma membrane and cell 391 
organelles (52). The purified membrane preparations revealed ER markers for both ER sheets and 392 
tubules, although the marker used for the ER sheets has been reported to be found also at the 393 
plasma membrane (48). However, it remains to be studied if the RC-carrying plasma membrane 394 
sheets are truly connected to the other membranes or if these membranes have the same density. 395 
Clearly, this enrichment was not observed in the mock samples, and thus, SFV infection modified 396 
the studied membranes. However, besides genome replication, expression of SFV structural 397 
proteins and host defense responses may affect different membranes. Another possibility is that 398 
SFV infection causes the re-localization of some cellular proteins. For example the late endosomal 399 
marker Rab7 was present in the purified RC-membrane fraction, but the endo-lysosomal marker 400 
LAMP-2 could not be detected and thus Rab7 could have been re-localized during infection. 401 
Membrane association of the replicase proteins, mediated mainly by nsP1, is indispensable 402 
for alphaviruses (25, 53, 54), and our results showed that detergent solubilization caused a 403 
significant loss of replication activity although the minus-strand template was stable (Fig. 1F and 404 
9C). Thus, the polymerase activity was sensitive to detergents further highlighting the importance 405 
of the membrane association of the RCs. Detergent solubilization has, however, been shown to 406 
increase the density of alphaviral RCs while they retain all nsPs and residual RNA synthesis activity 407 
(45). It remains to be studied whether the membrane association of SFV nsPs occurs only in the 408 
spherule neck or if they are also found inside the membrane invagination. Cryo-electron 409 
tomography of Flock house nodavirus (FHV) spherules has revealed a crown structure in the 410 
spherule neck with a 12-fold symmetry and a central electron density (12). It was suggested that 411 
FHV replicase protein A forms these structures, and if alphavirus RCs establish a similar structure, 412 
it may have a different organization as alphaviruses have four replicase proteins instead of one. 413 
We observed that the purified RCs incorporated 32P-CTP into both ssRNA and dsRNA and 414 
released newly made RNA (Fig. 9), and approximately 20-30% of the newly made genomic RNA 415 
was released as ssRNA. This data indicated that de novo initiation might occur in vitro. Secondly, 416 
we determined that the amount of genomic RNA present in the purified RCs was increased ~1.5 417 
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times during the in vitro replication. As the probe used recognizes an early part of the genome, the 418 
results indicate that long RNA strands were produced in vitro and consequently most in vitro 419 
synthesized strands were either de novo initiated or were re-initiated from a short RNA made in 420 
cells. Furthermore, the results also showed that high amounts of RNA was produced in vitro. So 421 
far, it is unclear how many copies of genomic RNA SFV spherules contain. FHV spherules are 422 
variable in size and the authors speculate that some spherules may contain more than one dsRNA 423 
or positive-strand RNA (12). 424 
In PNS, most of the in vitro synthesized RNA is single stranded (11, 40), and in vitro 425 
synthesized RF and RI reach the maximal level in about 15 min after which only the amount of 426 
ssRNA increases (55). In alphavirus-infected mammalian cells, CPVs are located close to the 427 
ribosome-rich ER and connecting bridges are formed that may represent RNA strands being 428 
translated. The release of the newly made RNA might thus require translation or nucleocapsid 429 
assembly and it has been suggested that these occur in a matrix between CPVs and the rough ER 430 
(36, 56). If the efficient release of the newly made RNA strands requires translation and assembly 431 
of the nucleocapsids close to the RCs, this may explain why most of the in vitro-synthesized RNA 432 
remained in membrane-associated, double-stranded replicative forms or intermediates. Although 433 
we observed SFV capsid protein and nucleocapsids in the purified membrane fraction (Fig. 6 and 434 
8), efficient encapsidation may not be achieved in vitro using purified membranes as no ribosomal 435 
RNA was detected.  436 
In conclusion, we showed that alphavirus infection strongly modifies cellular membranes 437 
beyond inducing the spherules and that the ER might be connected to the RC-carrying plasma 438 
membrane. This is the first step forward in extending our knowledge of alphavirus membrane-439 
associated RCs and further studies on these purified complexes should give insights into the host 440 
proteins present and required for their activity on the plasma membrane, as well as their 441 
structural organization. Currently, alphaviruses, coronaviruses and arteriviruses represent 442 
important groups of pathogenic positive-strand RNA viruses lacking structural information on 443 
RdRps (57, 58). The alphaviral core RdRp has been purified in an active form (31) but the structure 444 
of the RC might give more information about the active conformation of the polymerase and 445 
interactions, as all four nsPs are required for RNA synthesis.   446 
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Materials and Methods 447 
 448 
Cell culture, viruses and plasmids 449 
BHK-21 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich) 450 
supplemented with 10% (v/v) fetal bovine serum (FBS; Gibco), 2 mM L-glutamine (Gibco), 100 451 
U/ml penicillin (Gibco), and 100 µg/ml streptomycin (Gibco). BSR T7/5 cells, a derivative of BHK 452 
stably expressing T7 RNA polymerase (59), were cultured in DMEM supplemented with 10% FBS, 453 
2% (v/v) tryptose phosphate broth (Difco), 2 mM L-glutamine, 1% (v/v) non-essential amino acids 454 
(Gibco), 1 mg/ml G418 (Merck), 100 U/ml penicillin, and 100 μg/ml streptomycin. Both cell lines 455 
were grown at 37°C and in 5% CO2. The same conditions were used for virus infection and DNA 456 
transfection. SFV4-HA, containing a hemagglutinin (HA) peptide in frame within nsP3 in XhoI site, 457 
has been described and was propagated as previously (39). Secondary stocks of SFV4-HA were 458 
used in all virus infections. The polyprotein construct P123HA4 and template Tmed have been 459 
described previously (39, 60). 460 
 461 
Isolation of RCs from infected and transfected cells 462 
About 1×107 BHK-21 cells were infected with SFV4-HA at a MOI of 50 or 500 for 1 h or 20 min, 463 
respectively, in MEM containing 0.2% BSA and 2 mM L-glutamine. After the adsorption, cells were 464 
washed twice and fresh medium was added. Wortmannin (100 nm; Sigma-Aldrich) and nocodazole 465 
(5 µM; Calbiochem) treatments were performed as described previously (15). Nocodazole was 466 
added at the same time as the virus and Wortmannin at 1.5 h p.i. Cells were harvested at 4 h p.i. 467 
by trypsinization and PNS was prepared using a Dounce homogenizer as described in (39). BSR 468 
cells were co-transfected with the polyprotein and Tmed template plasmids and 16 h after 469 
transfection PNS and P15 membrane fractions were prepared as previously described (39). 470 
 471 
Purification of RCs from infected cells 472 
Approximately 4×107 BHK-21 cells were infected with SFV4-HA at a MOI of 500 and treated with 473 
wortmannin as above. Mock-infected cells served as a control and were treated with wortmannin. 474 
At 4 h p.i., cells were harvested by scraping in phosphate-buffered saline and washed with 475 
homogenization buffer (HB) [250 mM sucrose, 3 mM imidazole (pH 7.4), 2 μg/ml Actinomycin D 476 
(Sigma-Aldrich), Pierce EDTA-Free Protease Inhibitor (1 tablet per 10 ml; Thermo Fisher Scientific)] 477 
and resuspended in 500 µl of HB containing 200 U/ml RiboLock (Thermo Fisher Scientific). Cells 478 
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were disrupted using a 22-G needle and syringe by 24 up-and-down strokes. Unlysed cells and 479 
nuclei were removed by centrifugation (510 × g, 10 min, 4°C) yielding PNS which was diluted 3-fold 480 
with HB containing RiboLock. Membrane pellet (P7) and soluble fraction (S7) were prepared by 481 
further centrifugation of the diluted PNS (7,000 × g, 10 min, 4°C). The P7 fraction was washed once 482 
with and resuspended in HB containing RiboLock. 483 
RCs were purified from S7 fractions by sedimentation (100,000 × g, 3 h, 4°C) in a 484 
discontinuous iodixanol (Sigma-Aldrich) gradient consisting of 2.3-ml layers of 20, 17.5, 15, 12.5, 485 
and 10% (w/v) iodixanol in dilution buffer (DB) [250 mM sucrose, 35 mM HEPES (pH 7.4), 2.5 mM 486 
DTT, 7 mM KCl] containing Pierce EDTA-Free Protease Inhibitor (1 tablet per 10 ml). 500 µl of S7 487 
was loaded on the top of a gradient. After sedimentation, gradients were fractionated and protein, 488 
lipid and RNA composition as well as replication activity were analyzed as described below. 489 
Density of the fractions was measured by weighing. For further purification, the light-scattering 490 
zone between 12.5% and 15% iodixanol layers was collected and purified by equilibrium flotation 491 
centrifugation (90,000 × g, 18 h, 4°C) in a discontinuous iodixanol gradient consisting of 3 ml of 492 
30% and 1.8-ml layers of 26, 22, 18, 14, and 10% (w/v) iodixanol in DB. 30% layer contained the 493 
light-scattering zone collected from the sedimentation gradient. After flotation, gradients were 494 
fractionated and fractions analyzed as the sedimentation fractions. For further experiments, the 495 
light-scattering zone between 14% and 18% iodixanol layers was collected yielding purified RCs. As 496 
a control, membranes from wortmannin-treated mock-infected cells were purified using the same 497 
protocol. 498 
 499 
In vitro replication assays 500 
A standard 30-µl reaction without BSA contained 25 µl of PNS, 32 mM HEPES (pH 7.4), 225 mM 501 
sucrose, 2.3 mM DTT, 6.3 mM KCl, 1.7 μg/ml Actinomycin D, and 830 U/ml RiboLock. A standard 502 
30-µl reaction with BSA contained 22 µl of PNS, S7, P7, P15, sedimentation or flotation fractions, 503 
or purified RCs, 1 mg/ml BSA, 28 mM HEPES (pH 7.4), 200 mM sucrose, 2 mM DTT, 5.6 mM KCl, 1.5 504 
μg/ml Actinomycin D, and 810 U/ml RiboLock. In addition, both reactions contained 3 mM 505 
magnesium acetate, 17 mM creatine phosphate (Sigma-Aldrich), 8.3 U/ml creatine phosphokinase 506 
(Sigma-Aldrich), 1 mM ATP, 10 µM UTP, 10 µM GTP, 8.5 µM CTP, and 0.055 µM (5 µCi) of α-32P-507 
CTP (Perkin Elmer). If required, samples were diluted with DB, and if samples contained imidazole, 508 
6 mM magnesium acetate was used in the reaction mixture. Reactions were incubated at 30°C for 509 
1 h unless otherwise stated. After incubation, reactions were terminated by adding LiDS/LET [5% 510 
19 
 
lithium dodecyl sulfate, 20 mM Tris-HCl (pH 7.4), 100 mM LiCl, 2 mM EDTA, and 5 mM DTT] 511 
containing 80 µg/ml proteinase K and incubating for 15 min at 37°C. Unicorporated label was 512 
removed using RNase-free Micro Bio-Spin™ P-30 Gel Columns (Bio-rad), and acid phenol method 513 
was used to isolate RNA. 514 
To determine stability of RCs, PNS was incubated at 4°C for 3, 24 and 48 or diluted in DB or 515 
35.5% (w/v) iodixanol in DB and incubated at 4°C for 24 h. After incubation, aliquots were 516 
removed for total RNA isolation and in-gel hybridization to detect endogenous RNA (see below) 517 
and for an in vitro replication assay. To test detergent sensitivity, PNS was treated with 0.01-1% n-518 
Octylglucoside (w/v), Tx-100 (v/v), DOC (w/v), or SDS (w/v) in DB at 4°C for 1 h, followed by total 519 
RNA isolation and in-gel hybridization to detect endogenous RNA (see below) or a replication 520 
assay. To inhibit replication, 100 µM 3’-dCTP (TriLink BioTechnologies) was added to the reaction 521 
mixture. 522 
To follow the stability of newly synthesized RNA in the S7 fraction or purified RCs, 100 µM 3’-523 
dCTP and 220 ng of Tmed in vitro transcript were added in one aliquot and DB to another one 524 
after a 1-h replication assay. In vitro transcript was prepared using a SacI-linearized Tmed plasmid 525 
and mMESSAGE mMACHINE® T7 Transcription Kit (Ambion) according to manufacturer’s 526 
instructions. After a chase at 30°C, aliquots were removed and reactions were terminated as 527 
described above. 528 
Ability of RCs to use an exogenous template RNA was tested by adding 1 µg of Tmed in vitro 529 
transcript in a reaction mixture containing purified RCs. As a control, P15 from cells transfected 530 
with the polyprotein P123HA4 and template Tmed plasmids was used. Replication assay reactions 531 
were incubated at 30°C for 2 h and terminated as described above. In order to test Tx-100 532 
sensitivity of purified RCs, they were incubated with 1% Tx-100 for 1 h at 25°C. After incubation, 533 
aliquots were removed for total RNA isolation and in-gel hybridization to detect endogenous RNA 534 
(see below) or a replication assay. 535 
In order to determine how much the amount of genomic RNA increases during in vitro 536 
replication compared to the amount of genomic RNA present in the RCs after purification, 537 
replication assays were performed using purified RCs and reaction conditions described above for 538 
a standard reaction with BSA, except for that 10 µM CTP and no α-32P-CTP were used. In addition, 539 
a reaction devoid of NTPs was performed. After a 4-h incubation at 30°C, RNA was isolated and 540 
genomic RNA was detected by in-gel hybridization (see below). As a control, RNA was isolated 541 




RNA isolation, denaturing agarose gel electrophoresis and in-gel hybridization 544 
Total RNA from replication assay reactions, PNS, S7, and P7 samples, sedimentation and flotation 545 
fractions, and purified RCs was isolated using the acid phenol method and analysed by denaturing 546 
formaldehyde agarose gel electrophoresis as described previously (39). If required, spike RNA 547 
(Tmed or Tshort in vitro transcript) was added in the samples before RNA isolation to allow 548 
normalization. Tshort in vitro transcript was prepared from the Tshort plasmid (60) as described 549 
above for Tmed. 550 
In-gel hybridization to detect RNA molecules from dried gels using 32P-labeled 551 
oligonucleotides has been described previously (61). SFV4-HA negative-stranded RNA was 552 
detected with the probe HybSFV4neg_4 and genomic and subgenomic RNA were detected with 553 
the probe HybSFV4pos_5 (39). SFV4-HA genomic RNA and RNA II were detected with the probe 554 
HybSFV4pos_8 (5'-GTCAGCCTCAATATCAACATGCACTTT-3') complementary to nucleotides 95-121 555 
of the genome. Tmed RNA was detected with the probe HybTmedpos_2 (39). Tshort RNA was 556 
detected with the probe HybTmedpos_3 (5’-AGGTGTATAACAGGTCCTCTCATTAATT-3’) 557 
complementary to nucleotides 1,270-1,297. 18S rRNA was detected with the probe 5’-558 
ATGCCCCCGGCCGTCCCTCT-3’. 559 
Dried gels were exposed to Phosphor Imager screens to detect 32P-label, and the screens 560 
were scanned with a Typhoon 9410 imager (GE Healthcare). Quantity One software (Bio-rad) was 561 
used to quantify the incorporated label. Normalization of signals for variations in RNA recovery 562 
and loading was done based on quantification of 18S rRNA or spike RNA detected by in-gel 563 
hybridization.  564 
 565 
RNase treatments of products from an in vitro replication assay 566 
Replication assays were performed using purified RCs and 2-h reaction time and RNA was isolated 567 
as described above. Isolated RNA was treated with RNase Cocktail™ Enzyme Mix (Ambion) 568 
containing RNase A and T1 (final concentrations of 2.5 and 100 U/ml, respectively) or RNase III (50 569 
U/ml; NEBNext RNase III RNA Fragmentation module) under high salt conditions. RNase A/T1 570 
reaction contained 4×SSC (600 mM NaCl, 60 mM sodium citrate, pH 7.0) and RNase III reaction 571 
2×SSC (300 mM NaCl, 30 mM sodium citrate, pH 7.0) and 1× RNase III reaction buffer. After a 15-572 
min incubation at 37°C, proteinase K was added (80 µg/ml) and incubation was continued for 15 573 
min. RNA was precipitated as described in (39). Besides denaturing formaldehyde agarose gel 574 
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electrophoresis, RNA was analysed without denaturation in a 1.0% (w/v) agarose gel in Tris-575 
Borate-EDTA buffer after mixing with 2 volumes of Gel Loading Buffer II (Ambion). 576 
 577 
RNA release 578 
To study release of newly synthesized RNA, purified RCs were concentrated and iodixanol was 579 
removed by washing with DB in Amicon Ultra Centrifugal Filter Units (Merck Millipore; 50,000 580 
nominal molecular weight limit; 3,220 × g, 4°C). An in vitro replication assay was performed as 581 
described above and after 1, 2 and 3-h reaction time, aliquots were removed, diluted with DB and 582 
pellet and supernatant fractions were separated by differential centrifugation (20,600 × g, 15 min, 583 
4°C). The pellet was washed with DB, and the pellet and supernatant were treated with proteinase 584 
K (80 µg/ml) for 15 min at 37°C. RNA was isolated using the acid phenol method (39). 585 
 586 
Protein and lipid analyses 587 
Protein concentrations were measured using the Coomassie blue method (62), with BSA as a 588 
standard. PNS, S7, P7 and sedimentation and flotation fractions were analysed by SDS-589 
polyacrylamide gel electrophoresis (SDS-PAGE) with 4% (w/v) acrylamide concentration in the 590 
stacking and 10%, 12% or 16% (w/v) acrylamide concentration in the separation gel. 12% SDS-591 
PAGE gels were stained with Coomassie blue to show proteins. 16% SDS-PAGE gels were stained 592 
with Sudan Black B (Sigma-Aldrich) according to manufacturer’s instructions to detect lipids. After 593 
electrophoresis, Sudan Black B stains both lipids and lipoproteins. For Western blotting, proteins 594 
separated in 10% or 12% SDS-PAGE gels were transferred to AmershamTM ProtanTM Nitrocellulose 595 
Blotting Membrane (GE Healthcare). Membranes were blocked with 5% (w/v) non-fat dry milk 596 
powder in Tris-buffered saline (TBS) followed by incubation with rabbit polyclonal antibodies 597 
against SFV nsP1, nsP2, nsP3, or nsP4 (37) or mouse monoclonal antibody against β-actin (Sigma-598 
Aldrich) in TBS with 5% milk and 0.1% (v/v) Tween-20. Alternatively, membranes were blocked 599 
with 5% milk in TBS containing 0.1% Tween-20 followed by incubation with rabbit monoclonal 600 
antibody against SDHA (Cell Signaling), mouse monoclonal antibody against PMCA (Abcam), rabbit 601 
polyclonal antibody against Na,K-ATPase α (Cell Signaling), rabbit polyclonal antibody against 602 
calnexin (Abcam), rabbit polyclonal antibody against CLIMP-63 (Abcam), rabbit polyclonal antibody 603 
against RTN4A and RTN4B (Abcam), mouse monoclonal antibody against GM130 (BD Biosciences), 604 
mouse monoclonal antibody against Rab7 (Abcam), rabbit polyclonal antibody against LAMP-2 605 
(Novus Biologicals), or rabbit polyclonal antibody against SFV capsid protein (63) in TBS with 5% 606 
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(w/v) BSA and 0.1% Tween-20. The primary antibodies were detected with secondary antibodies 607 
IRDye®800CW donkey anti-rabbit IgG (Li-COR Biosciences) or Alexa Fluor 680 donkey anti-mouse 608 
IgG (Invitrogen) and Odyssey system (Li-cor). Quantification was performed with Image Studio 609 
Software (Li-COR). The antibody against RTN4A and RTN4B recognized only a band of about 50 kDa 610 
(49) indicating that the detected protein was RTN4B, and the result was confirmed using sheep 611 
polyclonal antibody against RTN4B (MRCPPUreagents). 612 
 613 
Electron microscopy 614 
The light-scattering zone between 14% and 18% iodixanol layers in the flotation gradient (see 615 
purification above) was collected and fixed with 2% (v/v) glutaraldehyde (Sigma-Aldrich) in 100 616 
mM HEPES (pH 7.4) on ice for 30 min. After fixation, membranes were pelleted by differential 617 
centrifugation (11,700 × g, 30 min, 4°C). Membrane pellets were washed, osmicated and 618 
embedded into resin (TAAB) using standard procedures and ultra-thin sections (60 nm) were cut, 619 
picked on single slot copper grids and post stained with lead and uranyl acetate. The homogeneity 620 
of the pellet was checked by systematic sectioning through the entire pellet. The micrographs 621 
were taken with a Jeol JEM-1400 transmission electron microscope operating at 80 kV at the 622 
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Figures and figure legends 784 
 785 
Figure 1. SFV RCs are stable and robust in RNA synthesis in vitro. (A) BHK cells were infected with 786 
SFV at a MOI of 50 and PNS was prepared at 4 h p.i. In vitro replication was studied by the 787 
incorporation of 32P-CTP into SFV RNA indicated by 26S, II and 42S. After the incubation times 788 
indicated, RNA was isolated and analysed in a denaturing agarose gel. Ribosomal 18S RNA (18S 789 
rRNA) was detected by in-gel hybridization from the same gel. (B) Kinetics of the incorporation of 790 
32P-CTP into 26S (blue) and 42S (green) RNA. Percentages indicate the incorporation compared to 791 
the last time point (100%). Data are presented as means ± standard deviation from two 792 
independent experiments. (C) Replication assay performed with either undiluted PNS or PNS 793 
diluted as indicated. 18S rRNA was detected as in A. For the undiluted sample, 1/10th of RNA was 794 
loaded compared to the others. (D) Stability of replication activity. PNS was pre-incubated at 4°C 795 
for 3, 24 and 48 h or PNS was diluted in dilution buffer (DB) or iodixanol and pre-icubated at 4°C 796 
for 24 h before a replication assay. Two last lanes show samples containing 1 mg/ml BSA or 100 797 
µM 3’-dCTP. 18S rRNA was detected by in-gel hybridization from the same gel. (E) Stability of 798 
endogenous RNA. To detect endogenous SFV minus and plus strands, total RNA was isolated after 799 
the same pre-incubations as in D and analysed by in-gel hybridization with specific probes. (F) 800 
Detergent sensitivity. PNS samples containing the indicated detergent concentrations were 801 
incubated at 4°C for 1 h and either used for a replication assay or total RNA isolation followed by 802 
in-gel hybridization. After the replication assay, the incorporation of 32P-CTP into 42S RNA was 803 
quantified and percentages indicate the incorporation compared to the untreated PNS. Lower 804 
panel shows the presence of endogenous minus strand RNA in the untreated and 1% detergent 805 
samples detected by in-gel hybridization. Numbers below the lanes indicate the percentage of 32P-806 
signal compared to the untreated sample. 807 
 808 
Figure 2. Spherule location and replication activity. At 4 h p.i. PNS samples were prepared from 809 
SFV-infected (MOI 500) BHK cells, treated with 100 nM wortmannin at 1.5 h p.i. or 5 µM 810 
nocodazole at 0 h p.i. or untreated. These samples were compared to the PNS samples prepared 811 
from SFV-infected (MOI 50) untreated cells to give the percentages indicated in A-C. Error bars 812 
represent standard deviations for two independent experiments. (A and B) Total RNA was isolated 813 
from the PNS samples and plus- and minus-strand RNA were detected by in-gel hybridization with 814 
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specific probes followed by quantification of 42S RNA. (C) In vitro incorporation of 32P-CTP into 815 
viral RNA. 42S RNA was quantified. 816 
 817 
Figure 3. Schematic of RC isolation and purification. Overview of the purification from cell 818 
harvesting to iodixanol density-gradient centrifugations. From the sedimentation gradient, band 3 819 
was collected for further purification by flotation. Band 2 obtained after the flotation represents 820 
the purified RCs. 821 
 822 
Figure 4. Distribution of proteins, lipids and RNA in the S7 and P7 fractions. PNS was prepared 823 
from mock or SFV-infected (MOI 500) BHK cells treated with wortmannin and separated into an S7 824 
supernatant and P7 pellet. (A and B) Protein and lipid profiles of PNS, S7 and P7 in an SDS-825 
polyacrylamide gel stained with Coomassie blue (A) or Sudan Black B (B), respectively. Numbers on 826 
the left indicate the molecular masses (kDa) of marker proteins. (C) Distribution of viral and 827 
cellular markers as studied by Western blotting. PMCA was used as a marker for the plasma 828 
membrane, GM130 for the Golgi, calnexin for the endoplasmic reticulum, SDHA for the 829 
mitochondria, Rab7 for the late endosomes, and β-actin for the cytosol. Numbers in parentheses 830 
indicate the percentage of the protein present in the S7 fraction of that in PNS. The first number is 831 
from mock samples and the second one from virus-infected samples. (D) Incorporation of 32P-CTP 832 
into SFV RNA in PNS, S7 and P7 prepared from SFV-infected cells. Numbers below the lanes 833 
indicate the amount of incorporation into 42S RNA as a percentage of the label incorporated in 834 
PNS. (E) Distribution of endogenous minus- and plus-strand RNA analysed by in-gel hybridization 835 
from PNS, S7 and P7 prepared from SFV-infected cells. As a control, a probe against 18S rRNA was 836 
used. Numbers below the lanes indicate the amount of 42S RNA as a percentage of that in PNS. 837 
 838 
Figure 5. Infection modulates cellular membranes. S7 was prepared from mock- and SFV-infected 839 
(MOI 500) BHK cells treated with wortmannin, and RCs were purified by a 3-h sedimentation in a 840 
10-20% iodixanol step gradient. After centrifugation, gradients were fractionated (fr. 1-12, from 841 
the top to the bottom; fr. 13, the pellet) and compared to S7. On the left, fractions from mock and 842 
on the right from SFV sample. Protein (A) and lipid (B) patterns were studied in an SDS-843 
polyacrylamide gel stained with Coomassie blue or Sudan Black B, respectively. Numbers on the 844 
left indicate the molecular masses (kDa) of marker proteins. (C) Western blotting shows the 845 
distribution of viral and cellular markers as in Fig. 4. Furthermore, Na,K ATPase was used as an 846 
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additional marker for the plasma membrane, LAMP-2 for the late endosomes and lysosomes, and 847 
CLIMP-63 and RTN4B as additional markers for the endoplasmic reticulum (sheets and tubules, 848 
respectively). The sample volumes loaded from the fractions in the Coomassie or Sudan-stained 849 
gels (A and B) and Western blot-gels (C) were about five and seven times larger, respectively, than 850 
the sample volume loaded from the original S7 shown on the right. 851 
 852 
Figure 6. SFV RCs concentrate with the plasma membrane, ER and late endosome markers. Light-853 
scattering band 3 from the sedimentation gradient was further purified by an 18-h flotation in a 854 
10-30% iodixanol step gradient. After centrifugation, gradients were fractionated (fr. 1-12, from 855 
the top to the bottom; fr. 13, the pellet) and compared to S7. On the left, fractions from mock and 856 
on the right from SFV sample. Protein (A) and lipid (B) patterns were analysed in an SDS-857 
polyacrylamide gel stained with Coomassie blue or Sudan Black B, respectively. Numbers on the 858 
left indicate the molecular masses (kDa) of marker proteins. (C) Distribution of viral and cellular 859 
markers studied by Western blotting as in Fig. 4. (D) Distribution of Na,K ATPase (plasma 860 
membrane), LAMP-2 (late endosomes and lysosomes), and CLIMP-63 and RTN4B (endoplasmic 861 
reticulum sheets and tubules, respectively) between flotation fractions 3-5 was analysed and 862 
compared to S7 by Western blotting. The sample volumes are as in Fig. 5. 863 
 864 
Figure 7. Purified RCs remain active in RNA synthesis. (A) Distribution of endogenous minus- and 865 
plus-strand RNAs between SFV sedimentation (left) and flotation (right) fractions studied by in-gel 866 
hybridization. 18S rRNA was detected from the same fractions. Fr. 1-12, from the top to the 867 
bottom. Fr. 13 is the pellet and S7 is shown for comparison. (B) In vitro replication activity of the 868 
same fractions as in A studied by 32P-CTP incorporation. (C) Comparison of in vitro replication 869 
activity of S7 and purified RCs after replication reactions were incubated 4 h. S7 and RCs indicate 870 
32P-CTP incorporation by the S7 fraction and the purified RCs, respectively. In A the volume from 871 
the fractions used for RNA isolation was about ~7.5 times larger compared to the S7 sample 872 
volume and in B and C 20-fold diluted S7 was used. 873 
 874 
Figure 8. Purified RC membranes contain spherule-like structures. SFV RCs were purified in 875 
subsequent sedimentation and flotation gradients, fixed and pelleted by differential centrifugation 876 
for thin-section EM. Mock samples served as a control. All micrographs shown are from SFV 877 
samples. (A) Membrane sheets observed in both SFV and mock sample. (B) Membranes with 878 
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spherical invaginations of about 50 nm in diameter typical of SFV only. This represents most likely 879 
plasma membrane sheets sectioned in a different orientation compared to A, resulting in vesicle-880 
like appearance. (C) Membrane sheet showing smaller round vesicles that may represent neck 881 
parts of spherule-like structures, indicated by arrows. (D-I) Close-ups of spherule-like structures 882 
indicated by arrows. In D white arrow heads indicate nucleocapsids. Scale bars, 1000 nm (A and B), 883 
100 nm (C-F) or 50 nm (G-I). 884 
 885 
Figure 9. Characterization of the in vitro replication activity of the purified RCs. (A) Stability of 886 
newly synthesized SFV genomic RNA. After a 60-min replication assay, 32P-CTP incorporation was 887 
blocked by the addition of 100 µM 3’-dCTP and incubation at 30°C was continued for an additional 888 
180 min. Graph on the left represents an assay with 10-fold diluted S7 and on the right with the 889 
purified RCs. At the indicated chase times radioactivity in 42S was quantified (yellow). As a control, 890 
a reaction without 3’-dCTP was quantified (blue). In addition, in vitro transcript of Tmed added in 891 
the reaction at a 0-min chase was quantified by in-gel hybridization (green). All values are 892 
presented as percentages of the values at the 0-min chase. (B) Purified RCs and additional 893 
exogenous template. Replication assay reactions were incubated 2 h. RCs indicates 32P-CTP 894 
incorporation by the purified RCs. RCs + Tmed RNA shows incorporation by the purified RCs after 895 
an exogenous Tmed RNA transcript was added. As a control, 32P-CTP incorporation by the P15 896 
membrane fraction from cells transfected with the P1234 polyprotein and Tmed template 897 
plasmids is shown and genomic and subgenomic (SG) Tmed are indicated. Lower panel shows the 898 
presence of Tmed detected by in-gel hybridization. (C) Detergent stability and sensitivity. Purified 899 
RCs were treated with 1% Tx-100 followed by an assay to detect replication (upper panel) and in-900 
gel hybridization to detect the minus-strand template RNA (lower panel). (D) ssRNA and RF/RI 901 
forms of in vitro synthesized RNAs. After a 2-h replication assay with the purified RCs, RNA was 902 
isolated and treated with RNase A/T1 or III under high salt conditions to specifically digest ssRNA 903 
or dsRNA, respectively, and analysed in denaturing (left) or non-denaturing (right) conditions. (E) 904 
Release of newly made RNA. A replication assay was performed with the concentrated purified 905 
RCs and after 60, 120 and 180 min replication reactions, aliquots were removed to prepare pellet 906 
and supernatant fractions followed by RNA isolation and analysis in a denaturing agarose gel. The 907 
schematic shows how 32P-CTP is incorporated into viral RNA during in vitro RNA synthesis resulting 908 
in dsRNA containing both a plus strand synthesized in cells (indicated by magenta) and in vitro 909 
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(indicated by orange). After a round of replication and release of the newly made plus strand, an 910 
RC contains only the in vitro synthesized plus strand if replication is semi-conservative. (F) Increase 911 
in the amount of RNA during in vitro replication. After a 4-h replication assay with the purified RCs 912 
and unlabeled NTPs (indicated by NTPs), RNA was isolated and genomic RNA was detected by in-913 
gel hybridization. No NTPs indicates a reaction without added NTPs and ctrl indicates a sample 914 
without any incubations before RNA isolation. 42S RNA was quantified and average percentages 915 
from two independent experiments are shown in the table.  916 









